Moreover, the identification of factors specifically triggering PYY induction both systemically and within the islets, may pave the way for an alternative cure to peptide therapeutics, thus overcoming their inherent weaknesses, like poor pharmacokinetic properties and stabilities, and yet achieving the same benefits for the treatment of diabetes. Here, PYY is linked to diabetes mellitus.